Advertisement

Abstract

In reviewing the many causes of bleeding disorders, it is easiest to categorize the bleeding disorders according to which component of the haemostatic mechanism is affected, the blood vessels, platelets, or the clotting factors. Bleeding disorders may be further classified as to whether the disorder is inherited or acquired. However, practically speaking it is probably best for anaesthesiologists and critical care physicians to focus on the diagnosis and treatment of acquired bleeding disorders since most patients with a hereditary bleeding disorder are usually under the care of a haematologist from an early age.

Keywords

Systemic Lupus Erythematosus Clotting Factor Disseminate Intravascular Coagulation Disseminate Intravascular Coagulation Bleeding Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Chong BH (1994) Clinical aspects of thrombocytopenias. Australian Family Physician 23: 1463–1465PubMedGoogle Scholar
  2. 2.
    Watson C, Schultz A, Wikoff H (1947) Purpura following estrogen therapy with particular reference to hypersensitivity to dietylstilbestrol and with a note on the possible relationship of purpura to endogenous estrogens. J Lab Clin Med 606Google Scholar
  3. 3.
    Harker LA, Finch CA (1969) Thrombokinetics in man. J Clin Invest 48:963–974PubMedCrossRefGoogle Scholar
  4. 4.
    Breddin HK, Radziwon P, Boczkowska-Radziwon B (1994) Laboratory monitoring of new antithrombotic drugs. Clin Lab Med 14:825–846PubMedGoogle Scholar
  5. 5.
    Bick R (1992) Hemostasis in liver and renal disease. In: Anonymous disorders of thrombosis and hemostasis: Clinical laboratory practice. ASCP, Chicago, p 239Google Scholar
  6. 6.
    Bick RL (1994) Disseminated intravascular coagulation. Objective laboratory diagnostic criteria and guidelines for management. Clin Lab Med 14:729–768PubMedGoogle Scholar
  7. 7.
    Triplett D (1978) Appendix C: Miscellaneous lists and forms. In: Triplett D (ed) Platelet function evaluation: Laboratory evaluation and clinical application. ASCP, Chicago, p 291Google Scholar
  8. 8.
    Rao AK, Walsh PN (1983) Acquired qualitative platelet disorders. Clin Haematol 12:201–238PubMedGoogle Scholar
  9. 9.
    Mehta JL, Kitchens CS (1987) Pharmacology of platelet-inhibitory drugs, anticoagulants, and thrombolytic agents. Cardiovasc Clin 18:163–179PubMedGoogle Scholar
  10. 10.
    Troianos CA, Ellison N (1991) Hematologic considerations in vascular surgery. In: Joel A, Kaplan MD (eds) Vascular anesthesia, 1st edn. Churchill Livingstone, New York, pp 549–563Google Scholar
  11. 11.
    Boral LI, Henry JB (1991) Transfusion medicine. In: Tomas RH, Henry JB (eds) Clinical & diagnosis management by laboratory methods, 18th edn. WB Saunders, Philadelphia, pp 930–975Google Scholar
  12. 12.
    Miller RD, Brzica SM Jr (1986) Blood, blood components, colloids and autotransfusion therapy. In: Miller RD (ed) Anesthesia, 2nd edn. Churchill Livingstone, New York, pp 1329–1367Google Scholar
  13. 13.
    Crosby ET (1992) Perioperative haemotherapy: i. indications for blood component transfusion. Can J Anaesth 39:695–707PubMedCrossRefGoogle Scholar
  14. 14.
    Bick RL (1994) Disseminated intravascular coagulation: Objective criteria for diagnosis and management. Med Clin North Am 78:511–543PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 1999

Authors and Affiliations

  • C. T. Petrovitch
    • 1
  1. 1.Dept. of AnaesthesiologyProvidence HospitalWashingtonUSA

Personalised recommendations